Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Core Viewpoint - Biohaven Ltd. has successfully closed its underwritten public offering of 6,052,631 common shares at a price of $47.50 per share, raising approximately$287.5 million in gross proceeds before expenses [1]. Group 1: Offering Details - The offering included the full exercise of the underwriters' option to purchase an additional 789,473 common shares [1]. - The net proceeds from the offering will be used for general corporate purposes [1]. Group 2: Underwriters - J.P. Morgan, Morgan Stanley, Jefferies, and TD Cowen are acting as the joint lead book-running managers for the offering [2]. Group 3: Regulatory Information - The shares were issued under an effective shelf registration statement on Form S-3 [4].